$SWAG
Stran & Company, Inc. Stock $swag

$swag Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023083884 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$23.34M	$19.30M	$27.95M
YoY Change	-16.48%	42.19%	121.33%
Cost Of Revenue	$14.60M	$12.93M	$14.60M
YoY Change	0.03%	38.63%	63.09%
Gross Profit	$8.739M	$6.371M	$13.35M
YoY Change	-34.53%	50.01%	263.21%
Gross Profit Margin	37.44%	33.01%	47.76%
Selling, General & Admin	$7.660M	$5.940M	$24.52M
YoY Change	-68.76%	21.31%	522.15%
% of Gross Profit	87.65%	93.23%	183.68%
Research & Development			$1.103M
YoY Change
% of Gross Profit			8.26%
Depreciation & Amortization	$466.2K	$390.0K	$194.0K
YoY Change	140.33%	108.17%	71.36%
% of Gross Profit	5.34%	6.12%	1.45%
Operating Expenses	$7.660M	$5.940M	$25.81M
YoY Change	-70.33%	21.31%	555.07%
Operating Profit	$1.079M	$431.7K	-$12.47M
YoY Change	-108.66%	-166.51%	4589.49%
Interest Expense	$238.2K	$220.0K	$10.51M
YoY Change	-97.73%	1618.75%	-14990.93%
% of Operating Profit	22.07%	50.96%
Other Income/Expense, Net	$61.33K	$460.9K	-$1.874M
YoY Change	-103.27%	-315.77%	121.98%
Pretax Income	$1.379M	$892.6K	-$3.828M
YoY Change	-136.02%	-203.47%	832.27%
Income Tax	$495.4K	$208.0K	-$914.0K
% Of Pretax Income	35.93%	23.3%
Net Earnings	$883.3K	$684.6K	-$2.914M
YoY Change	-130.31%	-199.49%	9727.99%
Net Earnings / Revenue	3.78%	3.55%	-10.43%
Basic Earnings Per Share		$0.04
Diluted Earnings Per Share	$0.01	$0.04	-$0.27
COMMON SHARES
Basic Shares Outstanding	18.57M shares	18.42M shares	18.63M shares
Diluted Shares Outstanding		18.52M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.45M	$19.69M	$15.39M
YoY Change	19.94%	-10.42%	-52.26%
Cash & Equivalents	$7.989M	$9.435M	$15.25M
Short-Term Investments	$10.46M	$10.26M	$9.780M
Other Short-Term Assets	$3.528M	$5.100M	$2.539M
YoY Change	38.95%	295.73%	126.04%
Inventory	$6.639M	$6.903M	$6.868M
Prepaid Expenses
Receivables	$20.47M	$16.53M	$14.44M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$49.09M	$48.23M	$48.57M
YoY Change	1.06%	18.54%	2.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.857M	$1.414M	$1.000M
YoY Change	185.63%	75.72%	62.4%
Goodwill
YoY Change
Intangibles	$9.659M	$10.31M	$6.272M
YoY Change	54.0%	88.91%	225.1%
Long-Term Investments			$7.404M
YoY Change			-96.8%
Other Assets	$11.00M		$1.074M
YoY Change	923.76%
Total Long-Term Assets	$12.52M	$13.07M	$8.057M
YoY Change	55.34%	83.38%	121.35%
TOTAL ASSETS
Total Short-Term Assets	$49.09M	$48.23M	$48.57M
Total Long-Term Assets	$12.52M	$13.07M	$8.057M
Total Assets	$61.60M	$61.30M	$56.63M
YoY Change	8.79%	28.21%	10.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.316M	$4.860M	$19.61M
YoY Change	-77.98%	70.71%	293.4%
Accrued Expenses	$3.091M	$1.680M	$12.14M
YoY Change	-74.53%	65.04%	957.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$2.870M	$3.080M	$1.810M
YoY Change	58.58%	72.98%
Total Short-Term Liabilities	$16.67M	$16.92M	$13.96M
YoY Change	19.43%	156.49%	78.21%
LONG-TERM LIABILITIES
Long-Term Debt	$4.587M	$4.880M	$60.85M
YoY Change	-92.46%	121.73%	6134.33%
Other Long-Term Liabilities	$797.6K	$860.0K	$32.99M
YoY Change	-97.58%	59.34%	4104.13%
Total Long-Term Liabilities	$5.384M	$5.741M	$3.306M
YoY Change	62.86%	109.5%	87.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.67M	$16.92M	$13.96M
Total Long-Term Liabilities	$5.384M	$5.741M	$3.306M
Total Liabilities	$22.05M	$22.67M	$17.26M
YoY Change	27.75%	142.7%	79.96%
SHAREHOLDERS EQUITY
Retained Earnings	$1.119M	$235.3K	$1.084M
YoY Change	3.24%	30.3%	-41.81%
Common Stock	$38.43M	$38.40M	$1.848K
YoY Change	2079494.75%	2071081.98%	-6.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$6.643M	$6.668M
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.55M	$38.64M	$39.36M
YoY Change
Total Liabilities & Shareholders Equity	$61.60M	$61.30M	$56.63M
YoY Change	8.79%	28.21%	10.59%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	$883.3K	$684.6K	-$2.914M
YoY Change	-130.31%	-199.49%	9727.99%
Depreciation, Depletion And Amortization	$466.2K	$390.0K	$194.0K
YoY Change	140.33%	108.17%	71.36%
Cash From Operating Activities	-$985.1K	-$5.710M	-$1.301M
YoY Change	-24.28%	46.15%	-66.99%
INVESTING ACTIVITIES
Capital Expenditures	$209.7K	$130.0K	-$155.0K
YoY Change	-235.29%	-180.96%	108.05%
Acquisitions
YoY Change
Other Investing Activities	-$44.86K	$30.00K	-$796.0K
YoY Change	-94.36%	-100.3%
Cash From Investing Activities	-$254.6K	-$100.0K	-$641.0K
YoY Change	-60.29%	-99.01%	760.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-215.3K	-20.00K	0.000
YoY Change		-98.95%	-100.0%
NET CHANGE
Cash From Operating Activities	-985.1K	-5.710M	-1.301M
Cash From Investing Activities	-254.6K	-100.0K	-641.0K
Cash From Financing Activities	-215.3K	-20.00K	0.000
Net Change In Cash	-1.455M	-5.830M	-1.942M
YoY Change	-25.08%	-63.35%	-106.18%
FREE CASH FLOW
Cash From Operating Activities	-$985.1K	-$5.710M	-$1.301M
Capital Expenditures	$209.7K	$130.0K	-$155.0K
Free Cash Flow	-$1.195M	-$5.840M	-$1.146M
YoY Change	4.26%	55.88%	-70.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18515206	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19702136	shares
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41038
	dei	Entity Registrant Name EntityRegistrantName	STRAN & COMPANY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3297200
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Heritage Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
	dei	Entity Address City Or Town EntityAddressCityOrTown	Quincy
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02171
	dei	Local Phone Number LocalPhoneNumber	800-833-3309
	dei	City Area Code CityAreaCode	800
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18573091	shares
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	9435090	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15253756	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	10257675	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9779355	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16530027	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14442626	usd
CY2023Q3	strn	Deferred Income Taxes Current DeferredIncomeTaxesCurrent	1334000	usd
CY2022Q4	strn	Deferred Income Taxes Current DeferredIncomeTaxesCurrent	841000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6903305	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	87459	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	796018	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	386884	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	2886051	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	910486	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	48229625	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48569130	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1413870	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10313107	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6272205	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1344160	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	784683	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	11657267	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7056888	usd
CY2023Q3	us-gaap	Assets Assets	61300762	usd
CY2022Q4	us-gaap	Assets Assets	56626108	usd
CY2023Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	3083215	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1809874	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	460464	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324594	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4858590	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1224071	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	608589	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4268990	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2023Q3	strn	Reward Program Liability RewardProgramLiability	2750000	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	278945	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	365303	usd
CY2022Q4	strn	Note Payable Wildman NotePayableWildman	162358	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16924275	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13955523	usd
CY2023Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	4883265	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	2845944	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	858214	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	460089	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5741479	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3306033	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18521332	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18521332	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18475521	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18475521	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	1853	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1848	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38397861	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38279151	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	235294	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1083553	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38635008	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61300762	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56626108	usd
CY2023Q3	us-gaap	Revenues Revenues	19303335	usd
CY2022Q3	us-gaap	Revenues Revenues	13576072	usd
	us-gaap	Revenues Revenues	52549688	usd
	us-gaap	Revenues Revenues	40642559	usd
CY2023Q3	strn	Purchases Expenses PurchasesExpenses	11603364	usd
CY2022Q3	strn	Purchases Expenses PurchasesExpenses	8388856	usd
	strn	Purchases Expenses PurchasesExpenses	32437178	usd
	strn	Purchases Expenses PurchasesExpenses	25843023	usd
CY2023Q3	strn	Freight Expenses FreightExpenses	1328603	usd
CY2022Q3	strn	Freight Expenses FreightExpenses	939865	usd
	strn	Freight Expenses FreightExpenses	3970268	usd
	strn	Freight Expenses FreightExpenses	3573830	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12931967	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9328721	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36407446	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29416853	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6371368	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4247351	usd
	us-gaap	Gross Profit GrossProfit	16142242	usd
	us-gaap	Gross Profit GrossProfit	11225706	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5939694	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4896386	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18369963	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13152774	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5939694	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4896386	usd
	us-gaap	Operating Expenses OperatingExpenses	18369963	usd
	us-gaap	Operating Expenses OperatingExpenses	13152774	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	431674	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-649035	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2227721	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1927068	usd
CY2023Q3	us-gaap	Other Income OtherIncome	242009	usd
CY2022Q3	us-gaap	Other Income OtherIncome	20471	usd
	us-gaap	Other Income OtherIncome	313738	usd
	us-gaap	Other Income OtherIncome	92124	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	183156	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2881	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	467415	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9023	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	35770	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-231214	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	134352	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-231214	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	460935	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-213624	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	915505	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-148113	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	892609	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-862659	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1312216	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2075181	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	208000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-174507	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-463957	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-393772	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	684609	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-688152	usd
	us-gaap	Net Income Loss NetIncomeLoss	-848259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1681409	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18515206	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19702136	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18515206	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19702136	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41611619	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1307362	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	118692	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-545814	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	42591859	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	48291	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1993510	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-447443	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	40199197	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	45385	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1182405	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-688152	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	38474025	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	39364552	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27383	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-694538	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	38697397	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	110055	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-838330	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	37969122	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5580	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	24303	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	684609	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	38635008	usd
	us-gaap	Net Income Loss NetIncomeLoss	-848259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1681409	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-493000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-432800	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1039320	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	496827	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	162358	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-142149	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-66785	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	143018	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	212368	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	134352	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-231214	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2087401	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1314252	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	35741	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1887586	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	409134	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13772	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-1975565	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	281079	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	806933	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2136562	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	615482	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-143289	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3635842	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-152250	usd
	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	-3250000	usd
	us-gaap	Increase Decrease In Customer Loyalty Program Liability IncreaseDecreaseInCustomerLoyaltyProgramLiability	-43878	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	-86358	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	114333	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3383722	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6536762	usd
	strn	Payments To Asset Acquisition Net Of Cash Acquired PaymentsToAssetAcquisitionNetOfCashAcquired	660340	usd
	strn	Payments To Asset Acquisition Net Of Cash Acquired PaymentsToAssetAcquisitionNetOfCashAcquired	449857	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	794486	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	350108	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	369452	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9929617	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1824278	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10729582	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	586363	usd
	strn	Contingent Earn Out Liabilities ContingentEarnOutLiabilities	525109	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	24303	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3175915	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1037362	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-610666	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2663662	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5818666	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19930006	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15253756	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32226668	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9435090	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12296662	usd
	us-gaap	Interest Paid Net InterestPaidNet	4747	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	29043	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	85163	usd
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	364552	usd
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	14444	usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	350108	usd
	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition	1735000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	1470344	usd
	strn	Non Cash Asset Acquisition NonCashAssetAcquisition	4551095	usd
	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	654069	usd
	strn	Reduction In Contingent Earnout Liabilities ReductionInContingentEarnoutLiabilities	70406	usd
	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-654069	usd
	strn	Reduction In Intangible Asset Associated With Contingent Earnout Liabilities ReductionInIntangibleAssetAssociatedWithContingentEarnoutLiabilities	-70406	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in">8.</td><td style="text-align: justify">Concentration of Credit Risk - Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of accounts receivable and deposits in excess of federally insured limits. These risks are managed by performing ongoing credit evaluations of customers’ financial condition and by maintaining all deposits in high quality financial institutions.</td></tr></table>
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2889345	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2094859	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1475475	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1094769	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1413870	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1000090	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">20.</td><td style="text-align: justify">Use of Estimates - The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.</td></tr></table>
CY2023Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10440663	usd
CY2023Q3	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-182988	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	10257675	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	9958475	usd
CY2022Q4	strn	Unrealized Gain Loss On Investment UnrealizedGainLossOnInvestment	-179120	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	9779355	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	249965	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	264160	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6240606	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6557040	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	662699	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	310524	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6903305	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6867564	usd
CY2023Q3	strn	Cost Of Sale Purchases CostOfSalePurchases	4064327	usd
CY2022Q4	strn	Cost Of Sale Purchases CostOfSalePurchases	3571942	usd
CY2023Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	794263	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	479715	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4858590	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4051657	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	7000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1318678	usd
CY2022	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4268990	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633148	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	633148	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	721608	usd
	strn	Revenue Recognized RevenueRecognized	-52549688	usd
CY2022	strn	Revenue Recognized RevenueRecognized	-58953467	usd
	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	56185530	usd
CY2022	strn	Amounts Collected Or Invoiced AmountsCollectedOrInvoiced	58865007	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4268990	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	633148	usd
CY2023Q3	strn	Reward Program Liability RewardProgramLiability	2750000	usd
CY2022Q4	strn	Reward Program Liability RewardProgramLiability	6000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	784683	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	383190	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	333072	usd
CY2023Q2	strn	Working Capital WorkingCapital	1462732	usd
CY2023Q2	strn	Intangible Customer List IntangibleCustomerList	5211435	usd
CY2023Q2	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	6674167	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2123072	usd
CY2023Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4551095	usd
CY2023Q2	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	6674167	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1344160	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	784683	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	460464	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324594	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	858214	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	460089	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	504630	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	399245	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	188359	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	192126	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	97176	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1381536	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2021Q4	strn	Number Of Shares Issued Per Unit NumberOfSharesIssuedPerUnit	1	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4478134	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4478134	shares
CY2021Q4	strn	Outstanding Voting Stock Percentage OutstandingVotingStockPercentage	0.654	pure
CY2022Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	1
CY2022Q1	us-gaap	Treasury Stock Value Acquired Par Value Method TreasuryStockValueAcquiredParValueMethod	10000000	usd
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1777657	shares
CY2022	strn	Treasury Stock Average Price Paid Per Share TreasuryStockAveragePricePaidPerShare	1.87
CY2022Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1777657	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	6667595	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	19502	shares
	strn	Treasury Stock Average Price Paid Per Share TreasuryStockAveragePricePaidPerShare	1.22
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1797159	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	6643289	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	143018	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	212368	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-years contractual terms.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0358	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2924	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1587000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3045700	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	50180	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.15
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1604820	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.06
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	109924	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.06
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1558000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.15
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	46000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	39001	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.11
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1564999	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.12
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	630228	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.13
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-848259	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18515206	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1681409	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19702136	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-848259	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18515206	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1681409	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19702136	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	48282	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-335000	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-318900	usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-335000	usd
	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-270618	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	29043	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-9254	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-158000	usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-113900	usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-128956	usd
	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-123154	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-463957	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-393772	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3114000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	174400	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1334000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	545800	usd
	us-gaap	Advertising Expense AdvertisingExpense	365682	usd
	us-gaap	Advertising Expense AdvertisingExpense	211945	usd
	dei	Document Type DocumentType	10-Q
CY2023Q3	strn	Note Payable Wildman NotePayableWildman		usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18515206	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19702136	shares
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1		usd
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred		usd
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1		usd
	strn	Non Cash Premier Asset Acquisition NonCashPremierAssetAcquisition		usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1		usd
	strn	Non Cash Asset Acquisition NonCashAssetAcquisition		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Expiredand Other Adjustments Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorExpiredandOtherAdjustmentsIntrinsicValue		usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
	strn	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Expiredand Other Adjustments Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorExpiredandOtherAdjustmentsIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001872525

Files In Submission

Name	View Source	Status
0001213900-23-083884-index-headers.html	Edgar Link	pending
0001213900-23-083884-index.html	Edgar Link	pending
0001213900-23-083884.txt	Edgar Link	pending
0001213900-23-083884-xbrl.zip	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
f10q0923ex10-1_stranandco.htm	Edgar Link	pending
f10q0923ex31-1_stranandco.htm	Edgar Link	pending
f10q0923ex31-2_stranandco.htm	Edgar Link	pending
f10q0923ex32-1_stranandco.htm	Edgar Link	pending
f10q0923ex32-2_stranandco.htm	Edgar Link	pending
f10q0923_stranandco.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_stranandco_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strn-20230930.xsd	Edgar Link	pending
strn-20230930_def.xml	Edgar Link	unprocessable
strn-20230930_lab.xml	Edgar Link	unprocessable
strn-20230930_pre.xml	Edgar Link	unprocessable
strn-20230930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SWAG
Stran & Company, Inc. Stock $swag

2023 Q4 Form 10-Q Financial Statement

#000121390023083884 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG Stran & Company, Inc. Stock $swag

2023 Q4 Form 10-Q Financial Statement

#000121390023083884 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SWAG
Stran & Company, Inc. Stock $swag